At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 27, 2026 at 08:00 ET
Novavax has filed definitive additional proxy materials, indicating an active shareholder vote or corporate action. The filing is routine administrative documentation related to corporate governance.
- Filing is a DEFA14A, which is definitive additional proxy materials
- Filed by the registrant (Novavax)
- No fee required for this filing
- Contains proxy statement information for corporate governance matters
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access